| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | TG-100-115 | CTRPv2 | pan-cancer | AAC | -0.094 | 0.02 |
| mRNA | BRD-K51831558 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.02 |
| mRNA | Midostaurin | GDSC1000 | pan-cancer | AAC | 0.094 | 0.02 |
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | -0.095 | 0.02 |
| mRNA | ABT-737 | CTRPv2 | pan-cancer | AAC | -0.09 | 0.02 |
| mRNA | WZ3105 | GDSC1000 | pan-cancer | AAC | -0.079 | 0.02 |
| mRNA | Lisitinib | GDSC1000 | pan-cancer | AAC | 0.091 | 0.02 |
| mRNA | ABT-263 | CTRPv2 | pan-cancer | AAC | -0.087 | 0.02 |
| mRNA | elocalcitol | CTRPv2 | pan-cancer | AAC | 0.084 | 0.02 |
| mRNA | ibrutinib | CTRPv2 | pan-cancer | AAC | -0.11 | 0.02 |